PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Roivant Sciences Inc., New York, NY, USA.\', \'Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.\', \'Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA, USA.\', \'Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.\', \'Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Melbourne, Victoria, Australia. jahami@unimelb.edu.au.\', \'Australian Institute for Musculoskeletal Science, The University of Melbourne and Western Health, St Albans, Melbourne, Victoria, Australia. jahami@unimelb.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41577-020-0357-7
?:doi
?:hasPublicationType
?:journal
  • Nature reviews. Immunology
is ?:pmid of
?:pmid
?:pmid
  • 32576980
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32576980>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32576980>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all